Abstract:Otosclerosis is a complex disease characterized by an abnormal bone turnover of the otic capsule resulting in conductive hearing loss. Recent findings have shown that angiotensin II (Ang II), a major effector peptide of the renin-angiotensin system, plays an important role in the pathophysiology of otosclerosis, most likely by its proinflammatory effects on the bone cells. Because reactive oxygen species play a role both in inflammation and in the cellular signaling pathway of Ang II, the appearance of protein adducts of the "second messenger of free radicals," the aldehyde 4-hydroxynonenal (HNE), in otosclerotic bone has been analyzed. Immunohistochemical analysis of HNE-modified proteins in tissue samples of the stapedial bones performed on 15 otosclerotic patients and 6 controls revealed regular HNE-protein adducts present in the subperiosteal parts of control bone specimens, whereas irregular areas of a pronounced HNE-protein adduct presence were found within stapedial bone in cases of otosclerosis. To study possible interference by HNE and Ang II in human bone cell proliferation, differentiation, and induction of apoptosis we used an in vitro model of osteoblast-like cells. HNE interacted with Ang II in a dose-dependent manner, both by forming HNE-Ang II adducts, as revealed by immunoblotting, and by modifying its effects on cultured cells. Namely, treatment with 0.1 nM Ang II and 2.5 μM HNE stimulated proliferation, whereas treatment with 10 μM HNE or in combination with Ang II (0.1, 0.5, and 1 nM) decreased cell proliferation. Moreover, 10 μM HNE alone and with Ang II (except if 1 nM Ang II was used) increased cellular differentiation and apoptosis. HNE at 5 μM did not affect differentiation nor significantly change apoptosis. On the other hand, when cells were treated with lower concentrations of HNE and Ang II we observed a decrease in cellular differentiation (combination of 1.0 or 2.5 μM HNE with 0.1 nM Ang II) and decrease in apoptosis (0.1 and 0.5 nM Ang II). Cellular necrosis was increased with 5 and 10 μM HNE if given alone or combined with Ang II, whereas 0.5 nM Ang II and combination of 1 μ M HNE with Ang II (0.1 and 0.5 nM) reduced necrosis. These results indicate that HNE and Ang II might act mutually dependently in the regulation of bone cell growth and in the pathophysiology of otosclerosis.

Effect of angiotensin II on inflammation pathways in human primary bone cell cultures in otosclerosis

The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis

Effects of angiotensinⅡ on expression of IL-6 in osteoblasts

Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis

[Physiopathology of otosclerosis. Preliminary research]

Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice

Proinflammatory Cytokines Enhance the Mineralization, Proliferation, and Metabolic Activity of Primary Human Osteoblast-like Cells

Oxidative stress in otosclerosis

Effect of Angiotensin II on Differentiation and Apoptosis of Chondrocytes in Cartilage Formation in the Process of Fracture Healing

Effects Of Cytokines On The Expression Of Angiotensin Ii Type 1 Receptors In Vascular Smooth Muscle Cells

PTH induces modification of transductive events in otosclerotic bone cell cultures

Osteoprotegerin Is Essential for the Development of Endothelial Dysfunction Induced by Angiotensin II in Mice

Effects of Indomethacin and Calcitonin on Bone Absorption in Type II Collagen-Induced Otosclerosis-Like Lesions in Rats

Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression

Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment

Identification of target proteins involved in cochlear otosclerosis

Possible inflammatory mediators in tympanosclerosis development

Dynamic Molecular Markers of Otosclerosis in the Human Cochlea

Inhibition of cellular communication network factor 1 (CCN1)-driven senescence slows down cartilage inflammaging and osteoarthritis

Angiotensin II Induces Monocyte Chemoattractant Protein‑1 Expression by Increasing Reactive Oxygen Species‑mediated Activation of the Nuclear Factor‑κb Signaling Pathway in Osteoblasts.

Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6